After opening the day negative, share markets in India continued the downward spiral and are currently trading in the red. Sectoral indices are trading on a mixed note, with stocks in the consumer durables sector and stocks in the realty sector witnessing maximum buying interest. While stocks in the metal sector are leading the losses.

The BSE Sensex is trading down by 120 points (down 0.4%) and the NSE Nifty is trading down by 50 points (down 0.5). Meanwhile, the BSE Mid Cap index is trading up by 0.2%, while the BSE Small Cap index is trading up by 0.4%. The rupee is trading at 64.66 to the US$.

In news from stocks in the pharma sector. Sun Pharma share price is in focus today. The stock opened the day down by over 2%, however it recovered most of the losses in the morning session.

The drugmaker announced the recall of 325,000 cartons off Zenatane (isotretinoin) capsules, used for treatment of severe acne, from the US market due to failed dissolution specifications.

As per the US health regulator, a class II recall is initiated in a “situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote”.

At the time of writing, Sun Pharma share price was trading up by 1.5%.

The Indian pharmaceutical industry has come under a lot of regulatory pressure in the past few years.

The sector has faced great volatility over the years.

‘Safe Haven’ Pharma Sector in Decline Since 2 Years

The list of pharma sector woes is long. So, is there light at the end of the tunnel? Girish Shetty, our research analyst thinks there is.

As per him, it doesn’t make sense to paint all pharma stocks with the same brush. The leaders of the industry will certainly survive this phase. There are interesting, niche pharma stocks that are worth your attention.